# Cold Sore Fever Blister Treatment

NDC: 55910-859
Generic name: Docosanol
Labeler / Manufacturer: Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)
Product type: HUMAN OTC DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CREAM
Routes: TOPICAL
Marketing started: 20231231
Marketing ended: 20280228
FDA application: ANDA212385

## Active ingredients

- DOCOSANOL: 100 mg/g

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"55910-859"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=55910-859
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5ecf678b-d08a-4082-9d01-4468865a94b2